|
1
|
Hirokawa N, Noda Y, Tanaka Y and Niwa S:
Kinesin super-family motor proteins and intracellular transport.
Nat Rev Mol Cell Biol. 10:682–696. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lawrence CJ, Dawe RK, Christie KR,
Cleveland DW, Dawson SC, Endow SA, Goldstein LS, Goodson HV,
Hirokawa N, Howard J, et al: A standardized kinesin nomenclature. J
Cell Biol. 167:19–22. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sekine Y, Okada Y, Noda Y, Kondo S, Aizawa
H, Takemura R and Hirokawa N: A novel microtubule-based motor
protein (KIF4) for organelle transports, whose expression is
regulated developmentally. J Cell Biol. 127:187–201. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kurasawa Y, Earnshaw WC, Mochizuki Y,
Dohmae N and Todokoro K: Essential roles of KIF4 and its binding
partner PRC1 in organized central spindle midzone formation. EMBO
J. 23:3237–3248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu C and Jiang W: Cell cycle-dependent
translocation of PRC1 on the spindle by Kif4 is essential for
midzone formation and cytokinesis. Proc Natl Acad Sci USA.
102:343–348. 2005. View Article : Google Scholar :
|
|
6
|
Wu G, Zhou L, Khidr L, Guo XE, Kim W, Lee
YM, Krasieva T and Chen PL: A novel role of the chromokinesin Kif4A
in DNA damage response. Cell Cycle. 7:2013–2020. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martinez NW, Xue X, Berro RG, Kreitzer G
and Resh MD: Kinesin KIF4 regulates intracellular trafficking and
stability of the human immunodeficiency virus type 1 Gag
polyprotein. J Virol. 82:9937–9950. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bernasconi P, Cappelletti C, Navone F,
Nessi V, Baggi F, Vernos I, Romaggi S, Confalonieri P, Mora M,
Morandi L, et al: The kinesin superfamily motor protein KIF4 is
associated with immune cell activation in idiopathic inflammatory
myopathies. J Neuropathol Exp Neurol. 67:624–632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Midorikawa R, Takei Y and Hirokawa N: KIF4
motor regulates activity-dependent neuronal survival by suppressing
PARP-1 enzymatic activity. Cell. 125:371–383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mazumdar M, Lee JH, Sengupta K, Ried T,
Rane S and Misteli T: Tumor formation via loss of a molecular motor
protein. Curr Biol. 16:1559–1564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carmeliet P: Angiogenesis in life, disease
and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Y: Positive and negative modulation of
angiogenesis by VEGFR1 ligands. Sci Signal. 2:re12009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahmad S and Ahmed A: Elevated placental
soluble vascular endothelial growth factor receptor-1 inhibits
angiogenesis in preeclampsia. Circ Res. 95:884–891. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu FT, Stefanini MO, Mac Gabhann F, Kontos
CD, Annex BH and Popel AS: A systems biology perspective on
sVEGFR1: its biological function, pathogenic role and therapeutic
use. J Cell Mol Med. 14:528–552. 2010.
|
|
16
|
Geissmann F, Manz MG, Jung S, Sieweke MH,
Merad M and Ley K: Development of monocytes, macrophages, and
dendritic cells. Science. 327:656–661. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clauss M, Weich H, Breier G, Knies U,
Röckl W, Waltenberger J and Risau W: The vascular endothelial
growth factor receptor Flt-1 mediates biological activities.
Implications for a functional role of placenta growth factor in
monocyte activation and chemotaxis. J Biol Chem. 271:17629–17634.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sawano A, Iwai S, Sakurai Y, Ito M,
Shitara K, Nakahata T and Shibuya M: Flt-1, vascular endothelial
growth factor receptor 1, is a novel cell surface marker for the
lineage of monocyte-macrophages in humans. Blood. 97:785–791. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crowther M, Brown NJ, Bishop ET and Lewis
CE: Micro-environmental influence on macrophage regulation of
angiogenesis in wounds and malignant tumors. J Leukoc Biol.
70:478–490. 2001.PubMed/NCBI
|
|
20
|
Hiratsuka S, Minowa O, Kuno J, Noda T and
Shibuya M: Flt-1 lacking the tyrosine kinase domain is sufficient
for normal development and angiogenesis in mice. Proc Natl Acad Sci
USA. 95:9349–9354. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kerber M, Reiss Y, Wickersheim A, Jugold
M, Kiessling F, Heil M, Tchaikovski V, Waltenberger J, Shibuya M,
Plate KH, et al: Flt-1 signaling in macrophages promotes glioma
growth in vivo. Cancer Res. 68:7342–7351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peppicelli S, Bianchini F and Calorini L:
Inflammatory cytokines induce vascular endothelial growth factor-C
expression in melanoma-associated macrophages and stimulate
melanoma lymph node metastasis. Oncol Lett. 8:1133–1138.
2014.PubMed/NCBI
|
|
24
|
Murakami M, Iwai S, Hiratsuka S, Yamauchi
M, Nakamura K, Iwakura Y and Shibuya M: Signaling of vascular
endothelial growth factor receptor-1 tyrosine kinase promotes
rheumatoid arthritis through activation of monocytes/macrophages.
Blood. 108:1849–1856. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murakami M, Zheng Y, Hirashima M, Suda T,
Morita Y, Ooehara J, Ema H, Fong GH and Shibuya M: VEGFR1 tyrosine
kinase signaling promotes lymphangiogenesis as well as angiogenesis
indirectly via macrophage recruitment. Arterioscler Thromb Vasc
Biol. 28:658–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsui M, Takeda Y, Uemura S, Matsumoto T,
Seno A, Onoue K, Tsushima H, Morimoto K, Soeda T, Okayama S, et al:
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates
atherosclerosis in chronic kidney disease. Kidney Int. 85:393–403.
2014. View Article : Google Scholar
|
|
27
|
Yamada KH, Nakajima Y, Geyer M, Wary KK,
Ushio-Fukai M, Komarova Y and Malik AB: KIF13B regulates
angiogenesis through Golgi to plasma membrane trafficking of
VEGFR2. J Cell Sci. 127:4518–4530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Exertier P, Javerzat S, Wang B, Franco M,
Herbert J, Platonova N, Winandy M, Pujol N, Nivelles O, Ormenese S,
et al: Impaired angiogenesis and tumor development by inhibition of
the mitotic kinesin Eg5. Oncotarget. 4:2302–2316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hemmings BA and Restuccia DF: The
PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol. 7:1–3. 2015.
View Article : Google Scholar
|
|
31
|
Park JK, Jeong JW, Kang MY, Baek JC, Shin
JK, Lee SA, Choi WS, Lee JH and Paik WY: Inhibition of the PI3K-Akt
pathway suppresses sFlt1 expression in human placental hypoxia
models in vitro. Placenta. 31:621–629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eubank TD, Roberts R, Galloway M, Wang Y,
Cohn DE and Marsh CB: GM-CSF induces expression of soluble VEGF
receptor-1 from human monocytes and inhibits angiogenesis in mice.
Immunity. 21:831–842. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Justiniano SE, Elavazhagan S, Fatehchand
K, Shah P, Mehta P, Roda JM, Mo X, Cheney C, Hertlein E, Eubank TD,
et al: Fcγ receptor-induced soluble vascular endothelial growth
factor receptor-1 (VEGFR-1) production inhibits angiogenesis and
enhances efficacy of anti-tumor antibodies. J Biol Chem.
288:26800–26809. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Michell BJ, Griffiths JE, Mitchelhill KI,
Rodriguez-Crespo I, Tiganis T, Bozinovski S, de Montellano PR, Kemp
BE and Pearson RB: The Akt kinase signals directly to endothelial
nitric oxide synthase. Curr Biol. 9:845–848. 1999. View Article : Google Scholar : PubMed/NCBI
|
